Policy supports healthy development - Jirong Pharmaceutical, a large-scale enterprise, has been shortlisted for the Hebei Pharmaceutical Industry Association
Release time:
2020-12-17 10:31
On December 10th, a training meeting for newly added industrial enterprises above designated size was held at the Huayang Holiday Hotel in Zhengding. Leaders from the Municipal Bureau of Industry and Information Technology and relevant leaders from the Bureau's Operations Department attended the meeting. The General Manager and Financial Director of Jirong Pharmaceutical also attended the meeting.
At the meeting, the leaders of the Municipal Bureau of Industry and Information Technology announced multiple support policies for enterprises above designated size. One of them is the implementation of key assistance, including the inclusion of enterprises above designated size in the "Hebei Province Government Enterprise Service Direct Information Platform", and the formation of a lawyer service team to conduct an annual "legal examination" for enterprises above designated size, actively helping enterprises coordinate and solve difficulties and problems encountered in production and operation. Secondly, prioritize financial services, increase financial support for enterprises above designated size, improve the government bank enterprise docking mechanism, encourage commercial banks to innovate financial products, simplify loan approval procedures, give priority to helping enterprises above designated size coordinate and solve their liquidity needs, and provide interest rate discounts in accordance with national policies and regulations to provide loan renewal and turnover services for eligible enterprises. Thirdly, the Industrial Growth Contribution Award has been established. The fourth is to implement precise and differentiated environmental protection governance measures. For the staggered production plan in autumn and winter and the emergency response plan for heavy pollution weather, priority should be given to ensuring the reasonable demands of enterprises above designated size, and ensuring the orderly production and reasonable release of advanced production capacity of compliant enterprises. This series of support and preferential measures has boosted our confidence and enthusiasm for the sustainable development of Jirong Pharmaceutical.
Related News
Premium L-Lysine HCL: Uses, Quality Standards & Sourcing 2026 Guide
This 2026 comprehensive guide breaks down core properties, grade classification, industrial applications, quality testing protocols and B2B sourcing tips for L-Lysine HCL, combining Jirong Pharmaceutical’s 22-year production experience of GMP-certified amino acid products to help global buyers select qualified, cost-effective raw materials that meet USP, EP and FDA regulatory standards.
Premium L-Lysine HCL: High Purity Pharmaceutical Grade Amino Acid
This 2026 E-E-A-T compliant guide for L-Lysine HCL covers its core definition, key industrial use cases, quality testing protocols, sourcing best practices and common industry questions. Backed by Jirong Pharmaceutical's 18 years of amino acid manufacturing experience, it provides authoritative, practical data to help formulators, bulk buyers and R&D teams make evidence-based procurement and product development decisions.
L-Lysine HCL: Premium Pharma Grade Amino Acid from Jirong Pharmaceutical
This comprehensive guide outlines core definitions, verified specifications, cross-industry applications, quality testing protocols, safety guidelines and 2026 market insights for L-Lysine HCL, leveraging Jirong Pharmaceutical’s on-site production experience to help global buyers make compliant, cost-effective procurement decisions aligned with latest regulatory requirements.
Premium Pharmaceutical Grade L-Lysine HCL 2026 | Jirong Pharmaceutical Complete Guide
This 2026 updated guide systematically introduces core attributes, production standards, application scenarios, purchasing tips and frequently asked questions of L-Lysine HCL. Backed by Jirong Pharmaceutical’s 14 years of amino acid manufacturing experience, it offers authoritative data to help B2B buyers select qualified high-quality L-Lysine HCL products easily.
L-Lysine HCL: 2026 Complete Guide to Pharma Grade Uses & Sourcing
This 2026 practical guide for L-Lysine HCL is developed based on Jirong Pharmaceutical’s 22 years of amino acid manufacturing experience, covering official definitions, application scenarios, quality testing criteria, common quality pitfalls and procurement tips, to help global pharma, nutrition and feed buyers source compliant, high-purity L-Lysine HCL products efficiently.
2026 Ultimate Guide to Pharmaceutical Grade Amino Acid: Benefits & Sourcing
This 2026 E-E-A-T compliant guide from Jirong Pharmaceutical covers core definitions, grading standards, evidence-backed benefits, common applications, and sourcing best practices for amino acid products. It integrates 2026 peer-reviewed research, 18+ years of production experience, and direct answers to top public queries, helping pharma manufacturers, supplement producers and end users make compliant, informed decisions.
Shijiazhuang Jirong Pharmaceutical Co., Ltd.
Address: No.8 North of Huagong Road, Circular Chemical Industry Zone, Shijiazhuang, Hebei, China
Sales line:86-0311-85157950
